
Number of publications published per year by Goto, Eriko. (Source : PubMed)

Distribution of publications types for Goto, Eriko. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors.
J. Viral Hepat.
2010;17;2
Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.
J. Immunol.
2009;183;11
Hemorrhagic Complications of Percutaneous Radiofrequency Ablation for Liver Tumors.
J. Clin. Gastroenterol.
2009
Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
Hepatology
2009;49;6

Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH.
Gut
2009;58;6

E3 ubiquitin ligases for MHC molecules.
Curr. Opin. Immunol.
2009;21;1

Agreement between stratus and visante optical coherence tomography systems in tear meniscus measurements.
Cornea
2009;28;2
Human bronchial intraepithelial T cells produce interferon-gamma and stimulate epithelial cells.
Clin. Exp. Immunol.
2009;155;2
Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation.
J. Gastroenterol.
2009;44 Suppl 19
Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma.
Am. J. Gastroenterol.
2008;103;12
[ See timeline ] [ See all publications ]
means that Goto, Eriko has 7 papers cited a least 7 times - methodology
Department of Gastroenterology, University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.